Introduction:
Osteoarthritis (OA) is the most common form of arthritis accounting for about 30% of general physician visits 1 . It may be defined as a heterogeneous group of conditions that lead to joint symptoms and signs which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone and at the joint margins 2 . It is usually classified as either primary (idiopathic) or secondary (associated with a known condition). Although OA is present by histologic or radiographic criteria in nearly 80% of people by the age of 80 years, only half have symtoms 3 , and these are often variable and intermittent. All though variable in its presentation and course of OA often carries significant morbidity 4 , related to its high prevalence, the reduced ability of those affected to perform both occupational and non-occupational activities 5 .Osteoarthritis is no longer considered a 'degenerative' or 'wear and tear' arthritis, rather involves dynamic biomechanical, biochemical and cellular process 6 . Although articular cartilage is at the center of change, OA is currently viewed as a disease of the entire joint and therefore, the failure of the joint as an organ 7 . Although symptoms are often unilateral, evidence of OA is almost always present bilaterally. However, even when symptoms are bilateral, there is a tendency for one side to be more symptomatic than the other. Unilateral disease may suggest OA secondary to trauma. In contrast to systemic inflammatory arthritis, OA lacks constitutional symptoms. OA is characterized clinically by pain, swelling of joint and limitation of motion. Pathologically & Radio logically the disease is characterized by focal erosive lesions, cartilage destruction, subchondral sclerosis, cyst formation and large osteophyte at the margin of the joints 8 . Diagnosis of OA knee is based on clinical and substantiated by radiological investigation.
The objectives in managing the patient with OA knee are: reducing/eliminating pain and stiffness, maintain/improve mobility, optimizing function and hence minimizing disability. Therapeutic approaches include pharmacological analgesics e.g. NSAID, intraarticular agents, glucosamine, hyaluronic acid and topical capsaicin, nonpharmacological e.g. patient education, exercise, personal contact, physiotherapy, assistive device, patellar tapping appropriate footwear and surgical intervention may be needed 9 . According to American College of Rheumatology (ACR) for mild symptomatic OA, treatment may include non-pharmacologic methods (patient education, physical & occupational therapy and other therapies), and pharmacologic therapy including non-opoid oral and tropical (i.e. applied to skin) analgesics. For patient who is unresponsive to this regimen, the use of non steroidal ant inflammatory drugs (NSAIDs) is considered appropriately. A corticosteroid injection is recommended for patients with knee OA, particularly when signs of local inflammation with joint effusion are present. Heat therapy is frequently prescribed to patients with symptomatic knee osteoarthritis (OA). Deep hyperthermia via localized micro wave diathermy (MWD) is effective in several musculoskeletal painful conditions [10] [11] [12] [13] [14] [15] [16] . Intrarticular (IA) corticosteroid injections have been used for decades in clinical practice for pain relief and control of local inflammation in OA [17] [18] [19] [20] [21] [22] [23] [24] . Intraarticular corticosteroid injection can be subside local inflammation with pain reduction and it can also reduce progression of structural changes 25 .
Published studies of the effect of a long acting corticosteroid intrarticular injection followed by physical modalities application in OA knee was scanty, moreover, there were less study on the functional impact of these combined therapy based on validated instruments, such as the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in knee OA. As OA knee involves dynamic biomechanical, biochemical and cellular process 6 , its management also include a combination of non-pharmacologic therapy, pharmacologic therapy. Hence, in this study a combined therapy of long acting intra-articular injection in addition to physical modalities of osteoarthritis of knee is given to find out the functional improvement and clinical outcome of the patient.
Methods:
This prospective interventional nonrandomized clinical study was conducted in the outpatient department of Physical Medicine & Rehabilitation, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, from October, 2011 to March, 2012. Study population were patients having primary mono or bilateral knee osteoarthritis with pain lasting for at least 6 months and having limitation/difficulty of movement of knee joint and osteoarthritis with radiological findings. Patients who were unwillingness to sign informed consent, previous surgery of the affected knee, intraarticular injections with steroids or hyaluronic acid, congenital or acquired inflammatory or neurological diseases involving the knee, taking chronic NSAID or steroid treatment, pregnancy or breastfeeding and contra indications to intraarticular injection were excluded from the study. The 54 patients were divided randomly in group A & B. Group A received NSAID (non steroidal anti-inflammatory drugs) i.e. aceclofenac 100mg twice daily for 10 days + omeprazol 20mg twice daily for 10 days + MWD (micro wave diathermy 20 minutes for 14 days. + therapeutic exercise + ADL (activities of daily living), while Group B received 80mg intraarticular triamcinolon acetonide injection once followed by NSAID i.e. aceclofenac 100mg twice daily for 10 days + omeprazol 20mg twice daily for 10 days + MWD 20 minutes for 14 days. + therapeutic exercise + ADL. In both groups the patients were observed for six weeks. Study parameters used to assess the disease activity & functional capability of the patients were: 1) Visual analogue scale (VAS), 2) Range of motion (ROM) and 3) Western Ontario and McMaster Universities (WOMAC) index. After taking the formal consent of the patient, details history was taken and a preset data form was filled up for every patient. Past history of illness & any systemic disease was inquired cautiously. Clinical examination was done systematically. Base line investigations were done e.g. CBC, ESR & Hb%, RBS, Serum creatinine, urine for R/M/E, serum uric acid & SGPT. X-ray of the affected knee joints were also done. All reports were properly recorded in the data sheet. Treatment was delivered in each group as per scheduled. Every patient was followed up in each week with up to six weeks. Data were analyzed by SPSS version 16.0.
Results:
The mean of age of patients in group A and B were 52.33±9.62 years and 52.29±9.67 years respectively (table-I). In group A, 9 (33.3%) were male and 18 (66.7%) were female. In group B, 10 (37.0%) were male and 18 (63.0%) were female (table-II). In Group A, highest number of patients had knee pain in both joins (48.1%) followed by right knee pain in 11 (40.7%) patients. Only 3 (11.1%) patients had pain in the left knee joint. In group B, more than half of the patients had knee pain in both joins (51.9%) followed by right knee pain in 9 (33.3%) patients. Only 4 (14.8%) patients had pain in the left knee joint ( 31 showed that single intraarticular injection of triamcinolone acetonide to patients with knee osteoarthritis provided short term pain relief and increased benefit was associated with both clinical evidence of joint effusion and successful aspiration of synovial fluid at the time of injection.
Uthman et al. 32 have studied 70 patients fulfilling the American College of Rheumatology criteria for primary knee osteoarthritis who were randomly chosen to receive intraarticular injections of a corticosteroid (40 mg triamcinolone acetonide) or a vehicle, at three month intervals, for a prospective period of two years. At the one and two year follow up evaluations, the patients injected with triamcinolone acetonide showed a trend toward greater symptom improvement, especially at the first year follow up, for the WOMAC pain subscale, night pain assessment, and the range of movement (p = 0.05) compared with patients injected with saline. Moreover, in a study by Raynauld et al. 33 showed that knee pain and stiffness were significantly improved throughout the two year study, by repeated injections of triamcinolone acetonide compared with saline injections.
However, one limitation of the present study was that it was conducted in a single centre in Dhaka city, which may not be representative for the whole country. Small sample size was also a limitation of this study. Due to time constraint patients were observed for six weeks only.
Conclusion:
Despite the lack of strong, convincing, and reproducible evidence that intraarticular therapy significantly alters the short term outcome and even less so the progression of osteoarthritis, corticosteroid injection is one of the mainstays of the management of osteoarthritis, in particular, osteoarthritis of the knee. In the present study there was statistically significant difference found in VAS, ROM, time taken to walk 50 feet and WOMAC index between the groups.
